Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Ovarian Neoplasms and FGFR2[original query] |
|---|
| Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases. Breast cancer research : BCR 2007 9 (6): R78. Huijts Petra E A, Vreeswijk Maaike P G, Kroeze-Jansema Karin H G, Jacobi Catharina E, Seynaeve Caroline, Krol-Warmerdam Elly M M, Wijers-Koster Pauline M, Blom Jannet C, Pooley Karen A, Klijn Jan G M, Tollenaar Rob A E M, Devilee Peter, van Asperen Christi |
| Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations. International journal of cancer. Journal international du cancer 2009 Feb 124 (3): 729-33. Gates Margaret A, Tworoger Shelley S, Terry Kathryn L, De Vivo Immaculata, Hunter David J, Hankinson Susan E, Cramer Daniel |
| Breast cancer susceptibility variants alter risk in familial ovarian cancer. Familial cancer 2010 Dec 9 (4): 503-6. Latif A, McBurney H J, Roberts S A, Lalloo F, Howell A, Evans D G, Newman W |
| FGFR2 mutations are rare across histologic subtypes of ovarian cancer. Gynecologic oncology 2010 Apr 117 (1): 125-9. Byron Sara A, Gartside Michael G, Wellens Candice L, Goodfellow Paul J, Birrer Michael J, Campbell Ian G, Pollock Pamela |
| Low penetrance alleles as risk modifiers in familial and sporadic breast cancer. Familial cancer 2012 Dec 11 (4): 629-36. Esteban Cardeñosa Eva, de Juan Jiménez Inmaculada, Palanca Suela Sarai, Chirivella González Isabel, Segura Huerta Angel, Santaballa Beltran Ana, Casals El Busto María, Barragán González Eva, Fuster Lluch Oscar, Bermúdez Edo José, Bolufer Gilabert Pascu |
| Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease. International journal of clinical and experimental pathology 2014 7 (4): 1708-13. Spiegelberg Christine, Giedl Johannes, Gaisa Nadine T, Rogler Anja, Riener Marc-Oliver, Filbeck Thomas, Burger Maximilian, Ruemmele Petra, Hartmann Arndt, Stoehr Robe |
| Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. BMC cancer 2015 15 (1): 415. Mackenzie Robertson, Kommoss Stefan, Winterhoff Boris J, Kipp Benjamin R, Garcia Joaquin J, Voss Jesse, Halling Kevin, Karnezis Anthony, Senz Janine, Yang Winnie, Prigge Elena-Sophie, Reuschenbach Miriam, Doeberitz Magnus Von Knebel, Gilks Blake C, Huntsman David G, Bakkum-Gamez Jamie, McAlpine Jessica N, Anglesio Michael |
| Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status. Cancer letters 2017 7 405 22-28. Sakai Kazuko, Ukita Masayo, Schmidt Jeanette, Wu Longyang, De Velasco Marco A, Roter Alan, Jevons Luis, Nishio Kazuto, Mandai Masa |
| MassArray analysis of genomic susceptibility variants in ovarian cancer. Scientific reports 2020 12 10 (1): 21101. Verma Sonali, Sharma Indu, Sharma Varun, Bhat Amrita, Shah Ruchi, Bhat Gh Rasool, Sharma Bhanu, Bakshi Divya, Nagpal Ashna, Wakhloo Ajay, Bhat Audesh, Kumar Rake |
- Page last reviewed:Feb 1, 2024
- Content source: